Association between platelet-to-high-density lipoprotein cholesterol ratio and future stroke risk: a national cohort

Xin Hou1, Meibao Zhu1, Zhenghao Zhu1

  • 1Department of Cardiology, The Third Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.

Frontiers in Neurology
|November 28, 2024
PubMed

Insights

Higher platelet-to-high-density lipoprotein cholesterol ratio (PHR) levels are linked to increased stroke risk. This finding helps identify individuals at high risk for stroke, aiding in preventative strategies.

Area of Science:

  • Cardiovascular Research
  • Biomarker Discovery
  • Epidemiology

Background:

  • The platelet-to-high-density lipoprotein cholesterol ratio (PHR) is recognized as a potential inflammatory biomarker, with established links to coronary artery disease severity.
  • Existing research provides limited evidence on the association between PHR and stroke incidence, necessitating further investigation.

Purpose of the Study:

  • To investigate the potential association between the platelet-to-high-density lipoprotein cholesterol ratio (PHR) and the risk of stroke.
  • To determine if PHR can serve as a predictive marker for stroke incidence.

Main Methods:

  • Utilized data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018.
  • Included 5,872 participants without a prior history of stroke, categorized into four baseline PHR quartiles.
  • Employed Cox proportional hazards regression, restricted cubic spline, and subgroup analyses to assess stroke outcomes.

Main Results:

  • Over a median follow-up of 77.5 months, 390 strokes occurred.
  • Participants in the highest PHR quartile exhibited a 49% increased stroke risk compared to the lowest quartile (HR 1.49).
  • Adjusted analyses confirmed a significant positive linear association between higher PHR levels and increased stroke risk.

Conclusions:

  • Elevated PHR levels are significantly associated with a higher risk of stroke.
  • PHR can be utilized as a valuable tool for identifying individuals at high risk of stroke.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
134
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
510
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
469